Chemical biology of type IV secretion systems

IV型分泌系统的化学生物学

基本信息

  • 批准号:
    10112950
  • 负责人:
  • 金额:
    $ 27.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-01 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Bacteria have evolved specialized nanomachines to deliver microbial cargo across the cell envelope. One versatile translocation apparatus, the type IV secretion system (T4SS), can be strategically deployed to inject macromolecular substrates into target bacterial or eukaryotic recipient cells. Despite their importance in bacterial pathogenesis and dissemination of antibiotic resistance determinants, the mechanisms by which the T4SS assembles and transports payload remain largely undefined. To address this knowledge gap, the long-term goal of this proposal is to develop and apply robust molecular tools to accelerate fundamental studies of T4SS nanomachines. The cag T4SS of the gastric bacterium Helicobacter pylori has emerged as an important system for understanding how a single molecular machine can transport diverse cargo into target cells. Whereas some T4SS have the capacity to secrete hundreds of proteins or DNA-protein complexes into the host cell, the ability to translocate a diverse repertoire of lipid, nucleic acid, protein, and polysaccharide substrates distinguishes the cag T4SS from other systems. Notably, the bacterial oncoprotein CagA is rapidly delivered to host gastric cells via cag T4SS mechanisms. Translocated H. pylori effector molecules activate innate defenses and dysregulate signaling pathways that influence progression of gastric disease; consequently, colonization by cag T4SS- positive H. pylori significantly augments the risk for gastric cancer. As a result of its central role in bacterial pathogenesis, the T4SS represents an ideal target for antimicrobials. In this application, we propose to identify and mechanistically characterize novel small molecule-based T4SS modulators. Iterative structure-activity relationship studies will be used to develop chemical scaffolds and pharmacophores with optimized anti-virulence potential. Probe development will take advantage of expertise and assay platforms in the Shaffer lab and will leverage synergistic resources in the proposed CPRI Computational Core (ligand-binding model development, rational design, virtual screening), CPRI Translational Core (high throughput assay support, novel compound repositories, and ADMET profiling), and the Organic Synthesis Core (medicinal chemistry and scale-up). Prioritized and validated chemical probes will be used in conjunction with biochemical and genetic approaches to interrogate cag T4SS regulation and dynamic steps in substrate translocation. Using a similar multidisciplinary approach, we will determine how the H. pylori cag T4SS apparatus assembles at the bacteria-host cell interface. Collectively, these studies will stimulate new basic research directions and will provide important insight into how the T4SS nanomachine orchestrates the delivery of specific molecular cargo to target cells to drive microbial pathogenesis. Furthermore, this work will generate powerful chemical tools that are broadly applicable to infectious disease research, and will identify potent lead compounds with the potential to disarm T4SS function in a variety of medically-relevant pathogens.
项目概要 细菌已经进化出了专门的纳米机器,可以在细胞膜上运送微生物货物。一 多功能易位装置,IV 型分泌系统(T4SS),可以战略性地部署来注射 大分子底物进入目标细菌或真核受体细胞。尽管它们在细菌中很重要 抗生素耐药性决定因素的发病机制和传播,T4SS 的机制 组装和运输有效载荷在很大程度上仍然没有定义。为了解决这一知识差距,长期目标 该提案的目的是开发和应用强大的分子工具来加速 T4SS 的基础研究 纳米机器。胃细菌幽门螺杆菌的 cag T4SS 已成为一个重要的系统 了解单个分子机器如何将不同的货物运输到目标细胞中。而有些 T4SS 能够将数百种蛋白质或 DNA-蛋白质复合物分泌到宿主细胞中, 易位多种脂质、核酸、蛋白质和多糖底物的特点是 来自其他系统的 cag T4SS。值得注意的是,细菌癌蛋白 CagA 被快速递送至宿主胃细胞 通过 cag T4SS 机制。易位的幽门螺杆菌效应分子激活先天防御并失调 影响胃病进展的信号通路;因此,cag T4SS-的定植 幽门螺杆菌阳性会显着增加患胃癌的风险。由于其在细菌中的核心作用 从发病机制来看,T4SS 代表了抗菌药物的理想靶点。在此应用中,我们建议确定 并对基于小分子的新型 T4SS 调制器进行机械表征。迭代结构-活动 关系研究将用于开发具有优化抗毒力的化学支架和药效团 潜在的。探针开发将利用 Shaffer 实验室的专业知识和检测平台,并将 利用拟议的 CPRI 计算核心中的协同资源(配体结合模型开发、 合理设计、虚拟筛选)、CPRI Translational Core(高通量分析支持、新型化合物 存储库和 ADMET 分析),以及有机合成核心(药物化学和放大)。 经过优先考虑和验证的化学探针将与生化和遗传方法结合使用 探究 cag T4SS 调节和底物易位的动态步骤。使用类似的多学科 通过这种方法,我们将确定幽门螺杆菌 cag T4SS 装置如何在细菌-宿主细胞界面处组装。 总的来说,这些研究将激发新的基础研究方向,并将提供重要的见解 T4SS 纳米机器协调将特定分子货物输送到目标细胞以驱动微生物 发病。此外,这项工作将产生强大的化学工具,广泛适用于 传染病研究,并将鉴定具有解除 T4SS 功能潜力的有效先导化合物 存在于多种医学相关的病原体中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carrie Shaffer其他文献

Carrie Shaffer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carrie Shaffer', 18)}}的其他基金

Chemical biology of type IV secretion systems
IV型分泌系统的化学生物学
  • 批准号:
    10569670
  • 财政年份:
    2020
  • 资助金额:
    $ 27.2万
  • 项目类别:
Chemical biology of type IV secretion systems
IV型分泌系统的化学生物学
  • 批准号:
    10333392
  • 财政年份:
    2020
  • 资助金额:
    $ 27.2万
  • 项目类别:
Determining the role of the CvpA protein in uropathogenic E. coli virulence
确定 CvpA 蛋白在尿路致病性大肠杆菌毒力中的作用
  • 批准号:
    8980943
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:
Determining the role of the CvpA protein in uropathogenic E. coli virulence
确定 CvpA 蛋白在尿路致病性大肠杆菌毒力中的作用
  • 批准号:
    9150294
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了